Ilana Schlam/X
Nov 19, 2024, 10:22
Ilana Schlam: Updated treatment algorithms for Breast Cancer include adjuvant Ribociclib and Inavolisib
Ilana Schlam, Breast Medical Oncologist and Assistant Professor of Medicine at Tufts University Medical Center, shared a post on X:
“Updated treatment algorithms for breast cancer now include adjuvant ribociclib and inavolisib, along with trial names.
Thrilled to see we’re truly running out of space in HR+ disease—progress is here, with much more to come for all breast cancer subtypes.”
Ilana Schlam, MD, is a breast medical oncologist and Assistant Professor of Medicine at Tufts University Medical Center. Her research focuses on precision medicine, drug development, and addressing healthcare disparities in breast cancer treatment and outcomes.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 23:56
Sep 7, 2025, 23:47
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25